Skip to main content
Signal8

Stamler David Allen

SEC insider (Form 3/4/5 filer). CIK 0002130205. Chief Executive Officer at ALTERITY THERAPEUTICS LTD (ATHE). 1 reported Form 4/5 transaction since Sep 2024; latest on Aug 31, 2026. Located in NEWARK, CA.

Companies Stamler David Allen has filed insider reports for

  • ALTERITY THERAPEUTICS LTD (ATHE): Director, Officer, Chief Executive Officer
Stamler David Allen profile photo

Stamler David Allen

CIK: 0002130205

Transaction Breakdown

Open Market Buys (P)1 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALTERITY THERAPEUTICS LTD logo
ATHE

ALTERITY THERAPEUTICS LTD

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • ALTERITY THERAPEUTICS LTD logo
    ATHE

    ALTERITY THERAPEUTICS LTD

    Aug 31, 2026
    Purchase

    Listed option exp 31 Aug 2026

    Direct
    47.6K shares at avg. $0.50-

1-1 of 1